Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiome and prostate cancer
Kazutoshi Fujita, Makoto Matsushita, Eri Banno, et al.
International Journal of Urology (2022) Vol. 29, Iss. 8, pp. 793-798
Closed Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Microbiome and Prostate Cancer: A Novel Target for Prevention and Treatment
Nataša Kuštrimović, R Bombelli, Denisa Baci, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1511-1511
Open Access | Times Cited: 48
Characteristics of the Gut Bacterial Composition in People of Different Nationalities and Religions
Mikhail Syromyatnikov, Ekaterina Nesterova, Maria Gladkikh, et al.
Microorganisms (2022) Vol. 10, Iss. 9, pp. 1866-1866
Open Access | Times Cited: 48
The Gut-Prostate Axis: A New Perspective of Prostate Cancer Biology through the Gut Microbiome
Kazutoshi Fujita, Makoto Matsushita, Marco A. De Velasco, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1375-1375
Open Access | Times Cited: 26
Age at diagnosis for lung, colon, breast and prostate cancers: An international comparative study
Hana Zahed, Xiaoshuang Feng, Mahdi Sheikh, et al.
International Journal of Cancer (2023) Vol. 154, Iss. 1, pp. 28-40
Open Access | Times Cited: 25
Microbiome and Prostate Cancer: Emerging Diagnostic and Therapeutic Opportunities
Sung Jin Kim, Myungchan Park, Ahnryul Choi, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 1, pp. 112-112
Open Access | Times Cited: 9
Overview of BPH: Symptom Relief with Dietary Polyphenols, Vitamins and Phytochemicals by Nutraceutical Supplements with Implications to the Prostate Microbiome
Kendal Stewart, Edwin D. Lephart
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5486-5486
Open Access | Times Cited: 22
Potential role of gut microbiota in prostate cancer: immunity, metabolites, pathways of action?
Cheng Zha, Peng Zheng, Kunyuan Huang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 18
Causal associations between gut microbiota and urological tumors: a two-sample mendelian randomization study
Mingdong Wang, Xiang Gao, Quan Yongjun, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Residential greenspace and risk of cancer: A prospective cohort study from the UK Biobank
Zhi Cao, Chenjie Xu, Shu Li, et al.
The Science of The Total Environment (2023) Vol. 871, pp. 162145-162145
Closed Access | Times Cited: 17
Pesticides: Unintended Impact on the Hidden World of Gut Microbiota
Asghar Ali, Khalid I. AlHussaini
Metabolites (2024) Vol. 14, Iss. 3, pp. 155-155
Open Access | Times Cited: 7
Investigating the causal role of the gut microbiota in esophageal cancer and its subtypes: a two-sample Mendelian randomization study
Jia Li, Xuedi Gao, Xiaoming Sun, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Long-Term Exposure to Nitrate and Trihalomethanes in Drinking Water and Prostate Cancer: A Multicase–Control Study in Spain (MCC-Spain)
Carolina Donat‐Vargas, Manolis Kogevinas, Gemma Castaño‐Vinyals, et al.
Environmental Health Perspectives (2023) Vol. 131, Iss. 3
Open Access | Times Cited: 15
Lactate as Key Metabolite in Prostate Cancer Progression: What Are the Clinical Implications?
Paolo Chetta, Renuka Sriram, Giorgia Zadra
Cancers (2023) Vol. 15, Iss. 13, pp. 3473-3473
Open Access | Times Cited: 15
Mechanisms of Prostate Cancer Cells Survival and Their Therapeutic Targeting
T. Pejcic, Zoran Todorović, Siniša Đurašević, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2939-2939
Open Access | Times Cited: 14
Prostate Cancer and the Mevalonate Pathway
Patricia Guerrero-Ochoa, Sergio Rodríguez-Zapater, Alberto Anel, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2152-2152
Open Access | Times Cited: 5
Differences in Gut Microbiota Profiles and Microbiota Steroid Hormone Biosynthesis in Men with and Without Prostate Cancer
Sofia Kalinen, Teemu Kallonen, Marianne Gunell, et al.
European Urology Open Science (2024) Vol. 62, pp. 140-150
Open Access | Times Cited: 5
Testis–Gut-Reproduction Axis: The Key to Reproductive Health
Hede Zou, Wenkang Chen, Baofeng Hu, et al.
Andrologia (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 5
Identifying distinctive tissue and fecal microbial signatures and the tumor-promoting effects of deoxycholic acid on breast cancer
Na Wang, Jun Yang, Wenjie Han, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 20
Targeting sex steroid biosynthesis for breast and prostate cancer therapy
Matti Poutanen, Malin Hagberg Thulin, Pirkko Härkönen
Nature reviews. Cancer (2023) Vol. 23, Iss. 10, pp. 686-709
Closed Access | Times Cited: 12
Determination of short-chain fatty acids as putative biomarkers of cancer diseases by modern analytical strategies and tools: a review
Petra Chaľová, Anton Ťažký, Ľudovít Škultéty, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
Bones and guts – Why the microbiome matters
Kelly F. Contino, Katherine L. Cook, Yusuke Shiozawa
Journal of bone oncology (2024) Vol. 44, pp. 100523-100523
Open Access | Times Cited: 4
PLA inhibits TNF-α-induced PANoptosis of prostate cancer cells through metabolic reprogramming
Yinghui Hao, Fangmei Xie, Jieyi He, et al.
The International Journal of Biochemistry & Cell Biology (2024) Vol. 169, pp. 106554-106554
Closed Access | Times Cited: 4
Icaritin-curcumol activates CD8+ T cells through regulation of gut microbiota and the DNMT1/IGFBP2 axis to suppress the development of prostate cancer
Wenjing Xu, Yingqiu Li, Lumei Liu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 4
Role of gut microbiota in the pathogenesis of castration-resistant prostate cancer: a comprehensive study using sequencing and animal models
Guo-Wen Lin, Feng Zhang, Xiaoling Weng, et al.
Oncogene (2024) Vol. 43, Iss. 31, pp. 2373-2388
Closed Access | Times Cited: 4
Cancer and the Microbiome of the Human Body
Lourdes Herrera‐Quintana, Héctor Vázquez‐Lorente, María López-Garzón, et al.
Nutrients (2024) Vol. 16, Iss. 16, pp. 2790-2790
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top